What is Dr. Zubair Khalid's research focus?

Dr. Zubair Khalid specializes in molecular virology, mRNA vaccine development, and computational biology, with a focus on avian pathogens like IBDV and Avian Reovirus.

Where is Dr. Zubair Khalid currently working?

Dr. Zubair Khalid is a Postdoctoral Research Associate at the University of Maryland (UMD), specifically within the Department of Animal and Avian Sciences.

Epigenetics Fundamentals: How Genes Are Controlled

By Dr. Zubair Khalid, DVM, MS, PhD · 2026-08-11

Every cell in your body contains the same DNA sequence—roughly 3.2 billion base pairs distributed across 23 pairs of chromosomes. A liver cell, a neuron, and a skin cell all share an identical genome. Yet they look different, behave differently, and express different proteins. The explanation lies not in the DNA sequence itself but in the molecular layers that determine which genes are switched on or off in each cell type. This regulatory overlay is the subject of epigenetics.

What Is Epigenetics?

Epigenetics is the study of heritable changes in gene expression that do not involve alterations to the underlying DNA sequence. The term comes from the Greek epi, meaning "above" or "on top of," and genetics. Epigenetic modifications act as a control system that tells cells which genes to read, when to read them, and how loudly.

To understand the distinction, consider a genetic mutation: a change in the nucleotide sequence, such as a C-to-T substitution in a coding region, that permanently alters the protein product. An epigenetic change, by contrast, does not change a single base pair. Instead, it modifies how the DNA is packaged, how accessible it is to the transcriptional machinery, or how the RNA products are processed. The DNA sequence remains identical; its expression profile changes.

The critical word in the definition is heritable. Epigenetic marks are passed on to daughter cells during mitosis, allowing a liver cell to divide and produce more liver cells, each maintaining the liver-specific gene expression pattern. This mitotic heritability is what distinguishes epigenetics from transient regulatory events like a transcription factor binding briefly to a promoter.

The Epigenome: A Layer Above the Genome

The complete set of epigenetic modifications in a cell is called the epigenome. If the genome is the book, the epigenome is the annotation system—the highlighted passages, the bookmarks, the sticky notes that tell you which chapters matter. The epigenome is cell-type-specific: a neuron and a muscle cell from the same person have identical genomes but different epigenomes.

The epigenome is also dynamic. It changes during development, in response to environmental signals, and with age. Unlike the genome, which is largely fixed at conception, the epigenome is plastic. This plasticity is both a feature and a vulnerability. It allows organisms to adapt to their environment, but it also means that harmful exposures can leave lasting molecular scars.

The Molecular Mechanisms of Epigenetics

Three principal mechanisms carry out epigenetic regulation: DNA methylation, histone modification, and non-coding RNAs. Each operates at a different level of gene control, and they often work together in coordinated regulatory programs.

DNA Methylation

DNA methylation is the covalent addition of a methyl group (–CH₃) to the fifth carbon of the cytosine base, producing 5-methylcytosine (5mC). In mammals, this modification occurs almost exclusively at cytosine residues followed by guanine—so-called CpG dinucleotides. The "p" denotes the phosphodiester bond linking the two nucleotides.

The human genome contains roughly 28 million CpG sites, but they are not evenly distributed. Many genes have CpG islands—regions of 300 to 3,000 base pairs with a high density of CpG dinucleotides—located near their promoters. When these promoter-associated CpG islands are methylated, the gene is typically silenced. Methylated CpG islands physically impede the binding of transcription factors and recruit proteins that compact the chromatin structure.

The enzymes responsible for adding methyl groups are the DNA methyltransferases (DNMTs). DNMT3A and DNMT3B establish new methylation patterns during development—they are the de novo methyltransferases. DNMT1 maintains existing patterns during DNA replication by copying methylation marks from the parental strand to the newly synthesized daughter strand.

Methylation is not permanent. The ten-eleven translocation (TET) enzymes oxidize 5mC to 5-hydroxymethylcytosine (5hmC) and further oxidation products, eventually leading to replacement of the modified cytosine with an unmodified one through base excision repair. This active demethylation pathway allows cells to erase methylation marks when gene activation is required.

Histone Modifications

DNA in the nucleus is wrapped around histone proteins to form chromatin. The fundamental repeating unit is the nucleosome: 147 base pairs of DNA wrapped around an octamer of four core histones—H2A, H2B, H3, and H4. Each histone has an N-terminal tail that protrudes from the nucleosome and is subject to a remarkable array of post-translational modifications.

Histone acetylation is the best-characterized modification. Histone acetyltransferases (HATs) add acetyl groups to lysine residues on histone tails, neutralizing the positive charge of the lysine and weakening the electrostatic interaction between the histone and the negatively charged DNA. This loosens the chromatin structure, making the DNA more accessible to transcription factors. Histone deacetylases (HDACs) reverse the reaction, restoring the positive charge and promoting chromatin compaction.

Histone methylation is more complex. Unlike acetylation, which is generally associated with gene activation, methylation can signal either activation or repression depending on which lysine or arginine residue is modified and how many methyl groups are added. For example, trimethylation of lysine 4 on histone H3 (H3K4me3) marks active gene promoters, while trimethylation of lysine 27 on histone H3 (H3K27me3) marks silenced genes. The writers of these marks are histone methyltransferases (HMTs), and the erasers are histone demethylases (KDMs).

Other modifications include phosphorylation, ubiquitination, and sumoylation. The combinatorial patterns of these marks form what has been called the "histone code"—a regulatory language that is read by effector proteins to determine chromatin state and gene activity.

Non-Coding RNAs

Not all epigenetic regulation occurs at the level of DNA or histones. A class of RNA molecules—non-coding RNAs (ncRNAs)—also participates in gene silencing. MicroRNAs (miRNAs) are short (~22 nucleotides) RNAs that bind to complementary sequences in messenger RNAs (mRNAs), typically in the 3' untranslated region, leading to mRNA degradation or translational repression. While miRNAs primarily act post-transcriptionally, they can also recruit chromatin-modifying complexes to target genes.

Long non-coding RNAs (lncRNAs) are transcripts longer than 200 nucleotides that do not encode proteins. Some lncRNAs function as scaffolds that bring chromatin-modifying enzymes to specific genomic loci. The classic example is XIST, the lncRNA responsible for X-chromosome inactivation in female mammals. XIST coats one of the two X chromosomes and recruits silencing complexes that establish repressive histone marks and DNA methylation across the entire chromosome.

How Epigenetic Marks Are Established and Maintained

Epigenetic regulation is not a static state but a dynamic process involving three classes of proteins: writers, readers, and erasers.

Writers, Readers, and Erasers

Writers are enzymes that deposit epigenetic marks. DNMTs methylate DNA; HATs and HMTs modify histones; RNA polymerases and associated factors produce non-coding RNAs. These enzymes are often recruited to specific genomic locations by sequence-specific DNA-binding proteins or by interactions with other chromatin-associated factors.

Readers are proteins that recognize and bind to specific epigenetic marks. The bromodomain is a protein module that binds acetylated lysines; the chromodomain and the Tudor domain bind methylated lysines and arginines. Reader proteins often recruit additional chromatin-modifying enzymes or transcription factors, thereby translating the epigenetic mark into a functional outcome. For example, the protein HP1 (heterochromatin protein 1) binds H3K9me3 and helps establish and maintain heterochromatin—the tightly packed, transcriptionally silent form of chromatin.

Erasers remove epigenetic marks. HDACs remove acetyl groups; KDMs remove methyl groups from histones; TET enzymes initiate DNA demethylation. The balance between writers and erasers determines the steady-state level of each mark, and this balance is itself regulated by developmental cues and environmental signals.

Maintenance During Replication

For epigenetic marks to be heritable, they must be copied when a cell divides. During S phase of the cell cycle, the DNA double helix is unwound and each strand serves as a template for synthesis of a new complementary strand. The parental histones, with their modifications, are distributed to the two daughter DNA molecules, and new unmodified histones are deposited to fill the gaps.

The maintenance DNA methyltransferase DNMT1 recognizes hemimethylated CpG sites—where the parental strand is methylated but the newly synthesized strand is not—and methylates the daughter strand. This ensures that the methylation pattern is faithfully copied. Histone modifications are propagated by a more complex mechanism: reader proteins on the parental histones recruit writer enzymes that modify the newly deposited histones, recreating the original pattern.

This maintenance process is not perfect. Some marks are lost or gained with each cell division, contributing to the gradual epigenetic drift observed during aging. The fidelity of epigenetic inheritance is high enough to maintain cell identity but low enough to allow for plasticity and adaptation.

Epigenetics in Development and Cell Differentiation

The development of a multicellular organism from a single fertilized egg is one of the most dramatic demonstrations of epigenetic control. Every cell in the body descends from that one zygote, yet cells acquire distinct identities through a process of progressive restriction.

Cellular Memory

Once a cell differentiates into a specific type, it must remember its identity through subsequent divisions. This cellular memory is encoded in the epigenome. A muscle cell maintains the muscle gene expression program because its epigenetic marks keep muscle-specific genes accessible and non-muscle genes silenced. The marks are copied during each division, ensuring that the daughter cells inherit the same expression program.

The stability of these marks varies. Some, like DNA methylation at CpG islands, are highly stable. Others, like certain histone modifications, are more dynamic. The combination of stable and labile marks allows cells to maintain their identity while remaining responsive to signals that require changes in gene expression.

Reprogramming in Early Embryo

The early embryo undergoes two major waves of epigenetic reprogramming. After fertilization, the paternal genome is actively demethylated within hours, while the maternal genome is passively demethylated over several cell divisions. This erasure removes most of the methylation marks inherited from the parents, returning the genome to a pluripotent state from which any cell type can develop.

A second reprogramming wave occurs in the primordial germ cells, the cells that will give rise to eggs and sperm. These cells erase their epigenetic marks and then establish new ones according to the sex of the embryo. This ensures that most epigenetic marks are reset between generations, although some escape this erasure—a phenomenon with important implications for transgenerational inheritance.

Environmental Influences on the Epigenome

The epigenome is sensitive to environmental inputs. Diet, stress, toxins, and other exposures can alter epigenetic marks, sometimes with lasting consequences for health. This sensitivity is an evolutionary adaptation that allows organisms to adjust their gene expression programs to their environment, but it also creates vulnerabilities.

Nutrition and Epigenetics

Many epigenetic enzymes require cofactors derived from the diet. DNA methyltransferases use S-adenosylmethionine (SAM) as the methyl donor. SAM is synthesized from methionine, an essential amino acid, and its production depends on folate, vitamin B12, vitamin B6, and choline. Deficiencies in these nutrients can reduce SAM levels and impair DNA methylation.

The most famous example of nutritional effects on the epigenome comes from the Dutch Hunger Winter of 1944–1945. During this period, a German blockade caused severe famine in the Netherlands. Children conceived during the famine were born with lower birth weights and, decades later, showed higher rates of metabolic disease. Studies of these individuals found altered DNA methylation at genes involved in growth and metabolism, including the insulin-like growth factor 2 (IGF2) gene. The epigenetic marks acquired in utero persisted for decades, demonstrating that early-life nutrition can have lifelong effects on the epigenome.

Stress and Epigenetics

Psychological stress also leaves epigenetic marks. The glucocorticoid receptor gene (NR3C1) is a key mediator of the stress response, and its expression is regulated by DNA methylation in the promoter region. Studies of individuals who experienced childhood abuse or neglect have found altered methylation at NR3C1 and other stress-related genes, changes that correlate with altered stress reactivity and increased risk of psychiatric disorders.

Animal models have shown that maternal care—specifically, the frequency of licking and grooming of pups—alters DNA methylation at the glucocorticoid receptor gene in the hippocampus. Pups that receive high levels of care have lower methylation and higher receptor expression, making them less anxious and more resilient to stress. These differences persist into adulthood, illustrating how early-life experiences become molecularly embedded.

Epigenetics and Disease

Given the central role of epigenetics in gene regulation, it is not surprising that epigenetic dysregulation contributes to a wide range of diseases. The most extensively studied is cancer, but epigenetic mechanisms are also implicated in neurological, metabolic, and autoimmune disorders.

Cancer Epigenetics

Cancer is traditionally viewed as a genetic disease caused by mutations in oncogenes and tumor suppressor genes. But cancer cells also exhibit profound epigenetic abnormalities. Global DNA hypomethylation—a loss of methylation across the genome—is a hallmark of many cancers and contributes to genomic instability. At the same time, hypermethylation of CpG islands at tumor suppressor gene promoters silences these protective genes.

For example, the tumor suppressor gene CDKN2A (which encodes p16, a cell cycle inhibitor) is frequently silenced by promoter hypermethylation in many cancer types. The DNA repair gene MLH1 is silenced by methylation in a subset of colorectal cancers, leading to microsatellite instability. These epigenetic changes can occur early in tumorigenesis, sometimes before the acquisition of driver mutations, suggesting that epigenetic dysregulation may be an initiating event in some cancers.

Histone modifications are also altered in cancer. Global loss of H4K16 acetylation and H4K20me3 is observed in many tumors, and mutations in histone-modifying enzymes are found in a significant fraction of cancers. The enzyme EZH2, a histone methyltransferase that writes H3K27me3, is overexpressed or mutated in lymphomas and other malignancies, making it an attractive therapeutic target.

Epigenetic Therapies

The reversibility of epigenetic marks makes them appealing targets for therapeutic intervention. Unlike genetic mutations, which are permanent, epigenetic changes can potentially be reversed with drugs. Two classes of epigenetic drugs are currently approved for clinical use.

DNA methyltransferase inhibitors, such as 5-azacitidine and decitabine, are nucleoside analogs that incorporate into DNA and trap DNMT enzymes, leading to their degradation and a passive loss of methylation. These drugs are used to treat myelodysplastic syndromes and acute myeloid leukemia, where they reactivate silenced tumor suppressor genes.

Histone deacetylase inhibitors, such as vorinostat and romidepsin, block HDAC activity, leading to increased histone acetylation and chromatin relaxation. These drugs are used to treat cutaneous T-cell lymphoma and other hematological malignancies. Many additional epigenetic drugs are in development, targeting histone methyltransferases, demethylases, and reader proteins.

Methods Used to Study Epigenetics

Studying epigenetic marks requires specialized techniques that can detect modifications at specific genomic locations and measure chromatin structure.

DNA Methylation Analysis

The gold standard for DNA methylation analysis is bisulfite sequencing. Treatment of DNA with sodium bisulfite converts unmethylated cytosines to uracil, while methylated cytosines are protected. After PCR amplification and sequencing, the presence of a cytosine indicates that the original base was methylated; a thymine indicates it was unmethylated. Whole-genome bisulfite sequencing (WGBS) provides single-base resolution of methylation across the entire genome, but at substantial cost. Reduced representation bisulfite sequencing (RRBS) enriches for CpG-rich regions, reducing the amount of sequencing required.

For targeted analysis, methylation-specific PCR (MSP) uses primers that discriminate between methylated and unmethylated DNA after bisulfite conversion. Pyrosequencing provides quantitative methylation measurements at specific CpG sites. Array-based methods, such as the Illumina Infinium MethylationEPIC array, measure methylation at over 850,000 CpG sites and are widely used in epidemiological studies.

Chromatin Accessibility and Histone Marks

Chromatin immunoprecipitation followed by sequencing (ChIP-seq) is the standard method for mapping histone modifications and transcription factor binding sites. Cells are treated with formaldehyde to crosslink proteins to DNA, the chromatin is sheared into fragments, and an antibody specific to the modification of interest is used to immunoprecipitate the protein-DNA complexes. The associated DNA is then purified and sequenced, revealing the genomic locations of the modification.

Chromatin accessibility can be measured by ATAC-seq (assay for transposase-accessible chromatin using sequencing). The Tn5 transposase preferentially inserts sequencing adapters into open chromatin regions. After sequencing, regions of high accessibility—which correspond to active promoters, enhancers, and other regulatory elements—are identified. DNase-seq and MNase-seq are alternative approaches that use enzymatic digestion to probe chromatin structure.

Non-coding RNAs are studied by RNA sequencing (RNA-seq), which captures all transcripts in a cell, including miRNAs and lncRNAs. Small RNA-seq uses size selection to enrich for short RNAs, allowing comprehensive profiling of miRNA expression.

Common Misconceptions and Pitfalls

The field of epigenetics has captured public attention, but this interest has also generated misconceptions. Understanding what epigenetics is—and is not—is essential for interpreting research findings and media reports.

Lamarckian Misinterpretation

Epigenetics is sometimes invoked as a modern vindication of Lamarckism—the idea that traits acquired during an organism's lifetime can be inherited by offspring. This is an oversimplification. While some epigenetic marks can be transmitted across generations, the vast majority are erased during reprogramming in the early embryo and in germ cells. Most epigenetic changes are somatic: they occur in body cells and affect only the individual, not their offspring.

Even when transgenerational inheritance does occur, it is not Lamarckian in the classical sense. The inheritance is not of a trait but of a molecular mark that influences gene expression, and the effects are typically subtle and context-dependent. The environment does not directly "write" adaptive information into the genome; it alters the probability of certain epigenetic states, and the consequences are often stochastic.

Transgenerational Inheritance Caveats

The evidence for transgenerational epigenetic inheritance in mammals is limited and controversial. Many reported effects are small, difficult to replicate, and confounded by genetic variation, maternal effects, and environmental continuity. The distinction between true transgenerational inheritance and parental effects is critical: if a mother's diet affects her offspring through epigenetic marks established in her germ cells, that is transgenerational. But if the effect is mediated by the intrauterine environment or by maternal behavior after birth, it is not.

In humans, the Dutch Hunger Winter studies are often cited as evidence for transgenerational epigenetic inheritance. However, the effects were observed in the children of women who were pregnant during the famine—these individuals were directly exposed in utero. Whether the effects extend to the grandchildren, who were not directly exposed, remains uncertain.

Correlation vs. Causation

Many epigenetic studies are observational, comparing methylation levels between groups with different outcomes. These studies can establish associations but not causation. A difference in DNA methylation between healthy and diseased tissue could be a cause of the disease, a consequence of it, or a marker of some other underlying process. Establishing causality requires experimental manipulation, such as altering methylation at a specific locus and observing the phenotypic consequences.

The field also faces technical pitfalls. Bisulfite conversion can be incomplete, leading to false methylation calls. ChIP-seq requires highly specific antibodies, and batch effects can confound comparisons across samples. Sample size, cell-type heterogeneity, and statistical power are persistent challenges, particularly in human studies where tissue samples are often mixtures of multiple cell types.

Summary and Key Takeaways

Epigenetics reveals that the genome is not a static blueprint but a dynamic readout system. The DNA sequence provides the potential, and the epigenome determines which parts of that potential are realized in each cell. The three main mechanisms—DNA methylation, histone modification, and non-coding RNAs—work together to establish and maintain cell identity, guide development, and respond to environmental signals.

The reversibility of epigenetic marks offers hope for therapeutic intervention in diseases like cancer, where epigenetic dysregulation is common and druggable. At the same time, the sensitivity of the epigenome to environmental exposures highlights the importance of early-life conditions and lifestyle factors in shaping long-term health.

For further reading on related topics, see Epigenetics Explained, Epigenetics Definition, and Epigenetics Important.

Frequently Asked Questions

What is epigenetics in simple terms?

Epigenetics is the study of changes in gene activity that do not involve changes to the DNA sequence itself. Think of the genome as a musical score and the epigenome as the conductor—the notes are the same, but the conductor decides which instruments play, how loudly, and when. Epigenetic marks tell cells which genes to turn on or off, and these instructions can be passed on when cells divide.

How does epigenetics affect gene expression?

Epigenetic marks affect gene expression by controlling access to the DNA. DNA methylation at gene promoters typically silences genes by blocking transcription factor binding and recruiting repressive proteins. Histone modifications can either open up chromatin to allow transcription (acetylation, H3K4me3) or compact it to block transcription (H3K27me3, H3K9me3). Non-coding RNAs can degrade messenger RNAs or recruit silencing complexes to specific genes.

Can epigenetic changes be inherited?

Yes, but with important caveats. Epigenetic marks are faithfully inherited during cell division, allowing cells to maintain their identity. Some marks can also be passed from parents to offspring through the germline, a phenomenon called transgenerational epigenetic inheritance. However, most marks are erased during early embryonic development, and the evidence for robust transgenerational inheritance in humans is limited.

What are examples of epigenetic modifications?

The three main types are DNA methylation (addition of methyl groups to cytosine bases), histone modifications (acetylation, methylation, phosphorylation, and other changes to histone proteins), and non-coding RNA-mediated regulation (such as microRNAs and long non-coding RNAs). X-chromosome inactivation in females, where one X chromosome is silenced by a combination of these mechanisms, is a classic example.

How is epigenetics studied?

Common methods include bisulfite sequencing for DNA methylation, ChIP-seq for histone modifications and protein-DNA interactions, ATAC-seq for chromatin accessibility, and RNA-seq for non-coding RNA expression. These techniques can be applied genome-wide or targeted to specific regions of interest.

Can lifestyle changes alter your epigenome?

Yes. Diet, exercise, stress, sleep, and environmental exposures can all influence epigenetic marks. For example, nutrients like folate and vitamin B12 affect the availability of methyl donors needed for DNA methylation. Exercise has been shown to alter DNA methylation in muscle and adipose tissue. However, the magnitude and persistence of these effects vary, and not all changes are beneficial or long-lasting.

What is the difference between genetics and epigenetics?

Genetics is the study of the DNA sequence itself—the genes and variants that are inherited from parents. Epigenetics is the study of how that sequence is regulated and expressed. Genetic changes alter the information encoded in DNA; epigenetic changes alter how that information is read. Both contribute to phenotype, but they operate through different mechanisms and have different timescales of inheritance.

Are epigenetic changes reversible?

Yes, unlike genetic mutations, most epigenetic changes are reversible. Enzymes that erase epigenetic marks—such as HDACs for histone acetylation and TET enzymes for DNA methylation—are active in cells. Drugs that inhibit writers (like DNMT inhibitors) or erasers (like HDAC inhibitors) can reverse epigenetic changes, which is the basis for epigenetic therapies in cancer. Lifestyle interventions may also influence the reversibility of certain marks.

Key Takeaways

Epigenetics is the study of heritable changes in gene expression that do not involve changes to the DNA sequence.
The three main molecular mechanisms are DNA methylation, histone modification, and non-coding RNA regulation.
Epigenetic marks are written, read, and erased by specific enzymes, and they are copied during cell division to maintain cell identity.
The epigenome is dynamic and responsive to environmental factors including nutrition, stress, and toxins.
Epigenetic dysregulation is a hallmark of cancer and contributes to many other diseases, and epigenetic drugs are already in clinical use.
Epigenetic changes are largely reversible, making them attractive therapeutic targets.
While some epigenetic marks can be inherited across generations, most are reset during development, and claims of transgenerational inheritance require careful scrutiny.